Status:
COMPLETED
Barrier Enhancement for Eczema Prevention
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Conditions:
Eczema
Eligibility:
All Genders
Up to 21 years
Phase:
NA
Brief Summary
The primary objective is to determine whether advising parents to apply emollient (moisturiser) to their child's skin for the first year of life in addition to best practice infant skin care advice ca...
Eligibility Criteria
Inclusion
- child has a first degree relative with parental reported doctor diagnosis of eczema, allergic rhinitis or asthma
- child up to 21 days old
- consenting adult has the ability to understand English
Exclusion
- preterm birth (defined as birth prior to 37 weeks gestation)
- sibling (including twin) previously randomized to this trial. If multiple births, the first child will be randomized into the trial.
- child has a severe widespread skin condition that would make the detection and/or assessment or eczema difficult
- child has a serious health issue, which, at parent or investigator discretion, would make it difficult for the family to take part in the trial
- any condition that would make the use of emollient inadvisable or not possible
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
1394 Patients enrolled
Trial Details
Trial ID
NCT04680520
Start Date
November 1 2014
End Date
January 1 2022
Last Update
November 28 2022
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Social and Community Medicine, University of Bristol
Bristol, United Kingdom
2
Queens Hospital
Burton, United Kingdom
3
Derby Childrens Hosptia
Derby, United Kingdom
4
Harrogate District Hospital
Harrogate, United Kingdom